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Interferon--Induced Endogenous Superantigen:
A Model Linking Environment and Autoimmunity
Multiple genes contribute to familial clustering of type
I diabetes, the MHC locus being the most important.
While genetic factors are necessary, they are per se
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Thierry Pelet,1 and Bernard Conrad1,3 not sufficient (Tisch and McDevitt, 1996). Environmental
1Department of Genetics and Microbiology factors and particularly viral infections have been pro-
University of Geneva Medical School posed to contribute to initiating and/or accelerating au-
1211 Geneva 4 toimmunity (Singh et al., 1998). Several lines of evidence
Switzerland support this. Clear correlations were found between ele-
2Department of Pathology vated levels of circulating IFN- and type I diabetes
Tufts University (Chehadeh et al., 2000b). In almost all cases of recent
Boston, Massachusetts 02111 onset diabetes, the pancreatic  cells contained IFN-
and this correlated with overexpression of the INF-
target gene MHC class I (Foulis et al., 1987). IFN- ex-
pression in pancreatic  cells is consistent with persis-Summary
tent viral infections (Chehadeh et al., 2000a). Transgenic
 cell-specific expression of type I IFNs caused type IWe earlier proposed that a human endogenous retrovi-
diabetes, and development of the disease depended onral (HERV) superantigen (SAg) IDDMK1,222 may cause
the genetic background of the mice (Stewart et al., 1993;type I diabetes by activating autoreactive T cells. Viral
Pelegrin et al., 1998). Finally, therapeutic administrationinfections and induction of interferon- (IFN-) are
of IFN- provoked type I diabetes in some individualstightly associated with the onset of autoimmunity.
with genetic risk factors (Beales and Pozzilli, 1999).Here we establish a link between viral infections and
HERVs entered the human genome after fortuitousIFN--regulated SAg expression of the polymorphic
germ line integration of exogenous retroviruses andand defective HERV-K18 provirus. HERV-K18 has
were subsequently fixed in the general population. Theythree alleles, IDDMK1,222 and two full-length envelope
may have been preserved to ensure genome plasticitygenes, that all encode SAgs. Expression of HERV-K18
and this can provide the host with new functions, suchSAgs is inducible by IFN- and this is sufficient to
stimulate V7 T cells to levels comparable to transfec- as protection from exogenous viruses and fusiogenic
tants constitutively expressing HERV-K18 SAgs. En- activity (Goff, 1996; Stoye and Coffin, 2000). IDDMK1,222
dogenous SAgs induced via IFN- by viral infections is a member of the HERV-K family, which has been
is a novel mechanism through which environmental assigned ten proviruses with distinct integration sites
factors may cause disease in genetically susceptible to date (Barbulescu et al., 1999). The provirus encoding
individuals. IDDMK1,222 has not yet been characterized. However,
proviruses similar to IDDMK1,222 with integration sites
in common with HERV-K18 were described (Tonjes etIntroduction
al., 1999; Hasuike et al., 1999; Barbulescu et al., 1999).
A sequence similar to both HERV-K18 and IDDMK1,222T cell-mediated autoimmune diseases, such as type I
was preliminarily mapped to the CD48 gene on chromo-diabetes, are thought to result from activation of autore-
some 1 using DNA from a single individual (Hasuike etactive T cells. Activation of autoreactive T cells may
al., 1999).be brought about by viral infections, via conventional
Here we provide a model linking viral infections andpresentation of viral peptides and bystander activation
autoimmunity via IFN--regulated SAg expression. First,or, alternatively, by SAgs (Steinman, 1995). Superanti-
we unambiguously identify that the polymorphic andgens are microbial proteins that sequentially bind to
defective HERV-K18 provirus in the CD48 gene has threeMHC class II proteins and the V chain of the T cell
alleles, one of which corresponds to IDDMK1,222. Sec-receptor and thereby strongly stimulate and expand T
ond, we analyze the population frequency of the threecells (Marrack et al., 1993). A dominant pancreatic en-
HERV-K18 alleles. The truncated and full-length HERV-richment of V7 T cells led to the detection of a V7-
K18 envelope alleles all encode SAgs with identicaland V13-specific SAg present in the protein fraction
specificity. The HERV-K18 SAgs are expressed at lowof inflammatory lesions from diabetic patients (Conrad
or not measurable levels in the absence of inductionet al., 1994). It turned out to be encoded by the truncated
and are strongly induced by IFN- with rapid kineticsenvelope gene of a HERV named IDDMK1,222 (Conrad
in peripheral blood lymphocytes (PBL). This is sufficientet al., 1997). Expansion of V7 and V13 T cells in the
to stimulate V7 T cells to levels comparable to thosecirculation closely correlates with and precedes the on-
set of the clinical disease (Luppi et al., 2000). The obtained with transfectants constitutively expressing
IDDMK1,222 SAg may therefore drive activation of autore- the SAg. In contrast, the other known HERV-K proviruses
active T cells in type I diabetes. are not IFN- inducible and are instead constitutively
expressed. This provides a novel mechanism for a model
linking environmental factors such as viral infections and3 Correspondence: bernard.conrad@medecine.unige.ch
4 These authors contributed equally to this work. autoimmunity via IFN--regulated endogenous SAgs.
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Figure 1. Three Alleles, IDDMK1,222 and Two Full-Length Envelope Genes, Are Encoded by HERV-K18, a Polymorphic and Defective Provirus
in the First Intron of the CD48 Gene
(A) HERV-K18 is integrated in an orientation opposite to the transcriptional direction of the CD48 gene. We precisely mapped the provirus
and confirmed the uniform presence and orientation of HERV-K18 in the first CD48 intron, on genomic DNA extracted from 30 healthy blood
donors.
(B) The env-LTR region of HERV-K18 is polymorphic. Shown are the deduced amino acid (aa) sequences of the 3 K18 envelope alleles and
the respective allele frequencies obtained from 120 different chromosomes of healthy blood donors. The surface (SU) and transmembrane
(TM) domains of the envelope protein are indicated by boxes. The position of polymorphic sites and aa changes are specified by arrowheads.
Allele K18.1 represents the first described sequence IDDMK1,222 encoding a V7 and -13 specific SAg in the 153 aa of the N-terminal SU
region. Alleles 2 and 3 encode full-length envelope proteins that also have SAg function. Two additional variants were found only once. The
candidate allele K18.1’ differs from K18.1 only in the 3 LTR. The candidate allele K18.2/3 is intermediate between alleles 2 and 3. The gag/
pol coding regions of all three alleles are defective (AF012336).
Results and Discussion as distantly related to the IDDMK1,222/K18.1 and K18.3
LTRs as it is from the HERV-K10 LTRs (7%). This ex-
plains why the IDDMK1,222/K18.1 LTR sequence origi-Three Alleles, IDDMK1,222 and Two Full-Length
Envelope Genes, Are Encoded by HERV-K18, nally appeared as an independent entity, identical nei-
ther to K18 nor to K10. Finally, an extended locus ona Polymorphic and Defective Provirus
in the First Intron of the CD48 Gene chromosome 1 also comprising CD48/HERV-K18 is a
candidate susceptibility region for type I diabetes (MeinWe first analyzed the genomic organization and se-
quence of the provirus within the first CD48 intron in et al., 1998).
both chromosomes of 60 healthy individuals. This aimed
at resolving all ambiguities in sequences similar to Expression of HERV-K18 in the CD48 Locus but Not
of Other Known HERV-K Proviruses Is Induced byIDDMK1,222 and assessing the IDDMK1,222 population
frequency. As indicated in Figure 1A, the integration site IFN-1/2 with Rapid Kinetics in PBL of All K18
Genotypes and Is Restricted to Non-T Cellsof the HERV-K18 provirus in the large first CD48 intron
was preserved in all individuals tested. The provirus We next sought to establish how exogenous viruses
could induce SAg expression. Type I IFNs are key regula-was inserted in the opposite transcriptional direction
to CD48. We then determined the envelope sequences tors of the innate host response to viruses. Therefore,
we asked whether SAg expression was regulated viabecause the SAg is encoded within the envelope gene.
In fact, the IDDMK1,222 SAg coding sequence was found IFN-. An initial hurdle was to discriminate unambigu-
ously HERV-K18 RNA from RNA of closely related, hu-in 46.6% of chromosomes and was designated allele
K18.1 (Figure 1B). Two envelope sequences similar to man-specific HERV-K proviruses. The latter can be sep-
arated in two groups within the SAg coding region, oneIDDMK1,222, but without its premature stop codon, were
obtained at frequencies of 42.5% (allele K18.2) and represented by HERV-K108 and the other by HERV-
K104. As shown in Figure 2A, transcripts from both10.8% (allele K18.3). K18.2 is identical to a published
sequence (Tonjes et al., 1999) and K18.3 is novel. Two groups can be distinguished from HERV-K18 RNA by
ribonuclease protection with a probe positioned in theadditional variants were found only once, and based on
their low frequency they may be either mutations or true SAg coding region. This permits study of HERV-K18
expression in response to stimuli such as type I and IIalleles. The first variant, candidate allele K18.1’, had an
envelope sequence identical to K18.1 but a divergent IFNs and lipopolysaccharide (LPS). In fact, as shown
in Figure 2B, HERV-K18 expression was inducible by3 LTR. The second variant, candidate allele K18.2/3,
had an envelope sequence intermediate between K18.2 IFN-1/2 with rapid kinetics in PBL of healthy individuals.
The known HERV-K proviruses were not inducible byand K18.3 (Y at position 97; W at position 154; V in
positions 272 and 348; I at position 534; [Figure 1B]). IFN-1/2 and were constitutively expressed in PBL. The
mean induction of HERV-K18 in PBL was 5-fold in 23The unambiguous assignment of IDDMK1,222 to HERV-
K18 had not been made previously for two reasons: genetically different individuals (5 3.2), as determined
by quantitative comparison with the TATA binding pro-first, because only HERV-K18 LTR sequences had been
available, and second, the published HERV-K18 LTR tein (TBP). This is an underestimation by a factor of
approximately 3, because the SAg is induced only insequence turned out to be identical to K18.2, which is
SAg Links Environment and Autoimmunity via IFN-
593
Figure 2. Expression of HERV-K18 but Not of Other Known HERV-K Proviruses Is Induced by IFN-1/2 with Rapid Kinetics in Primary Leukocytes
of All K18 Genotypes
(A) A riboprobe positioned in the HERV-K18 SAg coding region discriminates the SAg from other known HERV-K envelope transcripts. RNA
from the following conditions was hybridized with the K18 probe: the HERV-free mouse fibroblast cell line 3T3; 3T3 transfected with the
envelope allele K18.1; 3T3 transfected with the K104 envelope gene; 3T3 transfected with the K108 envelope gene; and an equimolar mix of
the above. The arrowhead on the top indicates the fragment protecting the K18 transcript and the arrowhead at the bottom indicates the
fragment protecting the K104 and K108 transcripts.
(B) HERV-K18 expression is strongly induced by IFN-1/2 with rapid kinetics. PBL from two healthy individuals were induced with IFN-1/2 for
1 hr. RNA from A20 mouse cells transfected with constructs expressing the HERV-K18 envelope, yeast RNA, and RNA from uninduced and
induced PBL samples were hybridized with the K18 probe. Arrowheads indicate the protected fragments specific for K18, K104/108, and
human TBP as internal control.
(C) HERV-K18 expression is strongly induced by IFN-1/2 in all K18 genotypes. The mean K18 mRNA induction in 23 PBL samples from healthy
donors was 5 3.2, as quantified by Phospho-Imager and corrected for the uninduced control TATA binding protein (TBP). Strong transcriptional
K18 inductions were obtained for all K18 genotypes.
(D) HERV-K18 expression induced by IFN- is derived from the CD48 locus. RNA from uninduced and IFN-1/2-induced PBL, from mouse A20
cells transfected with a cosmid bearing the complete K18 provirus, were hybridized with the K18 SAg probe and with a probe comprising
both the 3 proviral LTR and the flanking CD48 intron (“read-through” probe). The read-through probe detects only unspliced transcripts from
the CD48 locus. Arrowheads indicate the fragments specific for K18 SAg transcripts on the left-hand panel and K18 read-through transcript
on the right panel.
CD2– non-T cells, which constitute less than 30% of PBL We therefore generated a riboprobe that specifically
detects HERV-K18 read-through transcripts, which were(see supplemental data S1 at http://www.immunity.
com/cgi/content/full/15/4/591/DC1). With this in mind, elongated into the CD48 intron and were not yet cleaved.
The extent of induction of these read-through transcriptsstrong inductions were found for all K18 genotypes (Fig-
ure 2C). A riboprobe that discriminated expression of was comparable to that of the HERV-K18 SAg, namely
5-fold and7-fold, respectively (Figure 2D). This sug-individual K18 alleles confirmed that all alleles were simi-
larly induced by IFN-1/2 (S.M., unpublished data). gests that the IFN--induced SAg RNA was derived from
the CD48 locus and is also consistent with transcrip-Identical HERV-K18 transcripts could still derive from
multiple loci. The vast majority of nascent transcripts is tional activation of HERV-K18 by IFN-. In essence,
within the family of constitutively expressed HERV-Knot cleaved at the polyadenylation site and contains
heterogeneous 3 termini (Wuarin and Schibler, 1994). proviruses, HERV-K18 in the CD48 locus was excep-
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Figure 3. IFN-1/2-Regulated HERV-K18 Expression Is Canonical and Distinct from CD48
(A) The strong HERV-K18 induction with rapid kinetics is specific for IFN- and is superinduced by IFN-. An experiment similar to Figure 2B
was performed. The following experimental conditions were included in addition: PBL induced with IFN- alone, PBL induced with IFN-1/2 
, and PBL induced with LPS.
(B) The classical IFN- target gene 6-16 is induced similarly to the SAg in primary PBL while CD48 and the MHC class I isotype HLA-A are
induced weakly by IFN-1/2 with slow kinetics. PBL from a healthy blood donor were induced with IFN-1/2 for 1 and 16 hr or cultured for the
same time without treatment. Total RNA was hybridized with probes specific for CD48, HLA-A, K18 SAg, 6-16, and TBP as control. The 6-16
probe was designed to contain both the last exon and adjacent 3 intron. Both unspliced (6-16 uspl) and spliced transcripts (6-16 spl) were
detected.
tional regarding its low uninduced expression levels and weakly IFN- inducible (Hakem et al., 1991) (Figure 3B).
In contrast, the classical IFN- target gene 6-16 was asits IFN- inducibility restricted to non-T cells of all HERV-
K18 genotypes. strongly and rapidly induced in PBL as the SAg, namely
15-fold after 1 hr of treatment (Figure 3B). Spliced
and unspliced 6-16 transcripts were both induced. TheIFN-1/2-Regulated HERV-K18 Expression Is
Canonical and Distinct from CD48 transient accumulation of unspliced, nascent 6-16 tran-
scripts is consistent with transcriptional activation ofWe first asked whether HERV-K18 behaves as a classi-
cal IFN- target gene or whether stimuli such as type II the 6-16 gene by IFN-1/2. Finally, while IFN--induced
HERV-K18 expression was specifically restricted toIFNs and LPS also induce K18 expression. IFN- and
LPS alone had no stimulatory effect but combined treat- CD2– non-T cells (see supplemental data S1 at http://
www.immunity.com/cgi/content/full /15/4/591/DC1),ment of PBL with IFN-1/2  IFN- superinduced HERV-
K18 expression (Figure 3A). Thus, while type II IFNs expression of 6-16 was equally inducible in both T and
non-T cells, and the weak HLA-A and CD48 inductionsand LPS per se were not sufficient to induce HERV-
K18 expression, IFN- synergistically augmented IFN- appeared to be more pronounced in T cells (see sup-
plemental data S2 at http://www.immunity.com/cgi/induction, an effect known as IFN- priming (Levy et al.,
1990). NF-B inducing agents such as LPS and PMA content/full/15/4/591/DC1). These experiments indicate
that IFN-1/2-regulated HERV-K18 expression is distinctalone (Sutkowski et al., 2001) were not sufficient to in-
duce HERV-K18 expression. from CD48, regarding the cellular subset in which it is
induced, the magnitude and kinetics of induction, asWe next compared the kinetics and magnitude of SAg
induction in PBL with that of a classical IFN- target well as the signaling pathways used. Thus, HERV-K18
expression in the CD48 locus, but not expression ofgene 6-16 (Ackrill et al., 1991), the MHC class I isotype
HLA-A, and CD48. CD48 has been proposed to be induc- known HERV-Ks in other chromosomal locations, was
strongly induced with rapid kinetics by IFN-1/2 but notible by both type I and type II IFNs in certain cell lines
(Tissot et al., 1997). Two differences were apparent: first, IFN- and was superinduced by IFN- priming. In es-
sence, HERV-K18 behaves as a canonical IFN- targetuninduced CD48 expression was higher than uninduced
SAg expression, which was low in the absence of induc- gene with respect to all stimuli analyzed.
tion; second, CD48 was induced less rapidly and less
strongly than the SAg, namely less than 2-fold after 1 IFN-1/2-Induced HERV-K18 Expression Produces
a T Cell Mitogenic Effect in All K18 Genotypesand 16 hr instead of 5-fold after 1 hr of IFN-1/2 expo-
sure (Figure 3B). This was particularly true for primary We then reasoned that induction of HERV-K18 expres-
sion was expected to result in SAg function. In fact,leukocytes, where CD48 was not IFN-1/2 inducible at
all in certain donors. In that respect, CD48 was compara- PBL induced with IFN-1/2 exerted a mitogenic effect on
syngeneic T cells and efficiently induced T cell blastble to HLA-A, an MHC class I isotype known to be only
SAg Links Environment and Autoimmunity via IFN-
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1/2-treated PBL were used as APCs and cultured at
different ratios with T cells. After 24 hr, CD69 expression
was analyzed on total T cells, Sag-reactive V7 T cells,
and control V families. The unrelated V2 and V12 T
cells were selected because anti-V12 and -V7 anti-
bodies (Ab) share the same isotype, and V2 T cells
represent the single largest subset in the repertoire. In
two individuals homozygous for K18.1, IFN--induced
APCs activated 10%–30% of syngeneic T cells in a dose-
dependent fashion (Figure 5A). The levels of IFN--
induced transcriptional K18 activation correlated with
the strength of T cell activation. Namely, donor 1 with
12.7-fold transcriptional K18 induction had stronger T
cell activation than donor 2, which had an 8.5-fold K18
induction (supplemental data S5 at http://www.immunity.
com/cgi/content/full/15/4/591/DC1). When CD69 ex-
pression was analyzed on the V subsets of these two
donors, V7 T cells were stimulated more efficiently than
control Vs (Figures 5B and 5C). This was also true for
an individual homozygous for K18.2 (Figure 5D). While
CD4 and CD8 T cells were equally found among T
cell blasts before and after culture with untreated and
IFN--induced APCs, V7 T cells carrying the CD4 but
not the CD8 coreceptor appeared to be selectivelyFigure 4. IFN-1/2-Induced HERV-K18 Expression Produces a T Cell
activated by IFN--induced APCs, consistent with no-Mitogenic Effect in All K18 Genotypes
tion that HERV-K18 SAgs preferentially activate CD4 T(A) PBL from 21 healthy blood donors were cultured for 1 hr in
the presence or absence of IFN-1/2, washed, and added back to cells (see supplemental data S3 at http://www.immunity.
syngeneic PBL at equal ratios. After 2 1⁄2 days of culture, IL-2 was com/cgi/content/full/15/4/591/DC1). This is supported by
added for the last 24 hr. The percentage of blasts within the CD3 the fact that SAg- reactive T cell hybrids are absolutely
T cell population was determined by FACS, in uninduced and IFN- CD4 dependent (Sutkowski et al., 2001; our unpublished
-treated samples. As shown supplemental data S5 (see http://
data).www.immunity.com/cgi/content/full/15/4/591/DC1), strong induc-
Furthermore, V7 and to a lesser extent V13 T cellstions of T cell blasts were found in all K18 genotypes.
accumulated preferentially among T cell blasts in re-
sponse to IFN--treated PBL of five different individuals,
as compared to V12 (see supplemental data S6 atformation in all individuals analyzed (Figure 4; supple-
http://www.immunity.com/cgi/content/full/15/4/591/mental data S5 at http://www.immunity.com/cgi/content
DC1). In support of this, V7 T cells were also specifi-/full/15/4/591/DC1). An exception to this rule was only
cally enriched among T cells cultured with A20 transfec-three individuals with high uninduced levels of 15%
tants expressing K18.1, but not a K18.1 mutant with ablasts in CD3 T cells. Strong inductions of T cell blasts
premature frameshift mutation (F.M., submitted). Inwere found in all K18 genotypes, suggesting that all
these experiments, V7 enrichments correlated with theallelic K18 combinations were similarly mitogenic (sup-
presence of T cell proliferation. These finding are consis-plemental data S5 at http://www.immunity.com/cgi/
tent with the fact that V7 is a high-affinity V chain forcontent/full/15/4/591/DC1). Polymorphic genetic fac-
the endogenous K18 SAgs and are also consistent withtors other than the HERV-K18 genotype may influence
a quantitative model of T cell activation by the SAg.blast formation and could account for some of the differ-
According to this model, T cells carrying high-affinityences observed. For instance, different MHC class II
V chains are stimulated by the lowest doses of SAgisotypes and alleles differ in their capacity to bind and
and at the highest SAg doses all T cells are eventuallypresent both bacterial and endogenous SAgs of mice
stimulated (Fleischer et al., 1991). In essence, IFN-(Herman et al., 1990; Subramanyam et al., 1993).
treatment of PBL induced a T cell mitogenic activityWhether this also applies for human endogenous SAgs
consistent with specificity for SAg-reactive V7 CD4 Twill be addressed elsewhere. In essence, all HERV-K18
cells in all K18 genotypes analyzed.genotypes were induced similarly by IFN-1/2 and ex-
erted a comparable mitogenic effect.
IFN--Induced Expression of the Endogenous HERV-
K18 Locus Activates SAg-Reactive T Cells SimilarlyIFN--Induced HERV-K18 Expression Specifically
Activates Sag-Reactive CD4 V7 T Cells to the Transfected HERV-K18 Alleles
We next confirmed that the IFN--induced endogenousWe next analyzed whether IFN- induction of APCs spe-
cifically activates Sag-reactive V7 T cells. To answer K18 locus induces T cell proliferation similarly to trans-
fected K18 alleles. In fact, the capacity of IFN--treatedthis question we used two independent assays, one that
analyzes expression of the early T cell activation marker PBL from a K18.1/3 heterozygous individual to stimulate
proliferation of purified, syngeneic V7 T cells was com-CD69 (Simms and Ellis, 1996) on Sag-reactive and con-
trol T cells, and the other that measures V-specific parable to that of the transfected K18.1 and K18.3 alleles
(Figure 6A). Compatible with IFN--mediated transcrip-accumulation of T cell blasts (Kappler et al., 1989). IFN-
Immunity
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Figure 5. IFN--Induced HERV-K18 Expression Specifically Activates SAg-Reactive CD4 V7 T Cells
(A) IFN-1/2-treated PBL (APCs) activate syngeneic T cells dependent on the dose of APC and the strength of transcriptional K18 induction.
PBL from two individuals homozygous for K18.1 were induced with IFN-1/2. Donor 1 had a transcriptional induction of 12.7 and donor 2 had
8.5. IFN-1/2-treated and untreated APCs were cultured with syngeneic T cells at the indicated ratios for 24 hr and expression of the early T
cell activation marker CD69 was analyzed.
(B–D) IFN-1/2 activates SAg-reactive V7 T cells preferentially, as revealed by expression of the early T cell activation marker CD69 and
preferential accumulation of V7, and to a lesser extent V13 in T cell blasts. Expression of CD69 was analyzed on CD3V T cells after
culture for 24 hr with different doses of unstimulated and IFN-1/2-induced PBL (APCs) of donors 1 (B) and 2 (C) shown in 5A, as well as
APCs from a donor homozygous for K18.2 (D). Shown are the results obtained with CD69 blasts. In supplemental data S6 (see http://
www.immunity.com/cgi/content/full/15/4/591/DC1), the specific accumulation of V7 and V13 in blasting T cells after 3 1⁄2 days of culture
with IFN-1/2-treated syngeneic APCs was analyzed. Donor 2 had exceptionally high uninduced levels of V12 blasts that were not further
increased with SEB treatment, and donor 5 had exceptionally high uninduced levels of V7 blasts that were not further increased with IFN-
treatment.
tional activation of K18 in APCs, purified B lymphocytes sera but not the respective preimmune serum were ca-
pable of immunoprecipitating the SAg-HA fusion proteininduced with IFN-2a stimulated proliferation of syngenic
T cells with rapid kinetics, comparably to the polyclonal as efficiently as anti-HA Abs (Figure 7A). Therefore, the
antisera contained Abs that were able to bind the SAgmitogen PHA (Figure 6B). Collectively, IFN- treatment
of PBL and purified APCs induced the endogenous SAgs in solution. Next, crude antisera and affinity-purified
fractions from two independent immunizations weresimilarly to the SAg function encoded by transfected
K18 envelope alleles. compared with preimmune sera and with flow-through
fractions depleted of peptide-reactive Abs for their ca-
pacity to inhibit SAg function. In fact, the peak fractionAntibodies that Bind the SAg in Solution Inhibit SAg
Function of the IFN--Induced HERV-K18 Locus of affinity-purified IgGs from the first batch raised
against the N-terminal peptide (-N P-IgG1) inhibitedSimilarly to that of the Transfected HERV-K18 Alleles
To firmly establish that IFN--induced SAgs are en- the generation of blasts as consistently and efficiently
as monoclonal anti-MHC class II Abs directed againstcoded by HERV-K18, an attempt was made to specifi-
cally inhibit the SAg with anti-HERV-K18 envelope anti- HLA-DR, L243 (Figure 7B). Importantly, no significant
blast inhibitions were obtained for control Abs, suchbodies. Two independent batches of antisera against
N- and C-terminal SAg peptides were obtained by immu- as polyclonal Abs raised against recombinant HERV-K
envelope protein (85% and 63% of rabbit serum values)nizing rabbits on separate occasions. The peptide anti-
SAg Links Environment and Autoimmunity via IFN-
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Figure 6. IFN--Induced Expression of the Endogenous HERV-K18 Locus Activates SAg-Reactive T Cells Similarly to the Transfected HERV-
K18 Alleles
(A) SAg-reactive V7 human T cells were stimulated similarly by stably SAg transfected mouse B lymphoma cells (A20) and by IFN--induced
syngeneic APCs. Transfectants expressing the following constructs were used: the truncated envelope allele K18.1, the full-length envelope
K18.3, and the respective vector controls. As primary APCs, untreated PBL and IFN-1/2-induced PBL from a donor heterozygous for K18.1/3
were used. After 48 hr of culture, 3H-Thymidine incorporation of purified primary V7 T cells was measured.
(B) Purified B cells cultured in the presence of CD40L were induced with IFN-2a, treated with PMA, and used to stimulate syngeneic T cells.
After 48 hr of culture, 3H-Thymidine incorporation was measured.
and the respective preimmune serum (78% and 64% of ion by affinity-purified -N IgGs, and this inhibition was
lost upon depletion of -N Abs. Inhibition of IFN--rabbit serum values). In addition, the peak fraction of
affinity-purified IgGs raised against the C-terminal SAg induced blast formation with crude -N antisera was
less consistent than it was in assays with the transfectedpeptide only marginally inhibited blasts, if at all (Figure
7B). Thus, while both the anti-N and -C antisera were SAg (Figure 7C). In Figure 7E, the observation is ex-
tended to four additional, independent donors. Whileable to bind the SAg in solution, only anti-N Abs inhibited
SAg function as efficiently as anti-HLA-DR Abs. there was a significant inhibition of IFN--induced T
cell blast formation with affinity-purified -N IgGs in allLikewise, the crude anti-N antiserum obtained from
the second immunization (-N S2) but not the respective donors (p 	 0.02, t-Test), the immunodepleted fraction
had lost this ability (p	 0.01, t-Test). The affinity-purifiedpreimmune serum inhibited activation of SAg-reactive
V7 T cells by transfectants constitutively expressing Abs from the second immunization (Figure 7E) appeared
to inhibit less efficiently than the corresponding fractionthe K18.3 SAg (Figure 7C). This inhibition was, first, effi-
cient, because it inhibited V7 T cell proliferation to from the first batch (Figure 7B). However, this could also
be explained by the overall less stronger induction of Tlevels observed with vector transfected APCs and, sec-
ond, specific, because PHA-induced polyclonal activa- cell blasts in Figure 7E. In summary, two independent
batches of anti-peptide antisera and affinity-purified IgGtion was not influenced.
To confirm the specificity of this inhibition, we com- fractions bound the SAg in solution and inhibited the
SAg function of the IFN--induced endogenous K18 lo-pared the peak fraction of affinity-purified IgGs and the
flow-through fraction depleted of peptide-reactive Abs cus and of the transected K18 gene. This inhibition was
removed by immunodepletion of peptide-reactive Abs.from the second immunization for their ability to inhibit
IFN--induced T cell blast formation. As determined by These experiments therefore suggest that the IFN--
induced blast formation is generated by the HERV-K18ELISA, peptide reactivity was significantly enriched and
carrier reactivity was significantly diminished in affinity- SAgs and not by other IFN--induced target genes.
During attempts to titrate different type I IFN prepara-purified as compared to flow-through fractions. As
shown in Figure 7D, the capacity to inhibit SAg func- tions, we noticed a differential responsiveness of the
K18 locus to IFNs. The chimeric IFN-1/2 induced K18 attion had been depleted from the flow-through fraction,
yet it was present in the affinity-purified IgGs (see also least 3 times more strongly than IFN-2a and IFN- (S.M.,
unpublished data). This appeared to be specific for K18,supplemental data S4 at http://www.immunity.com/cgi/
content/full/15/4591/DC1). Shown is the average of two because the control gene 6-16 was induced with equal
efficiency by these different IFN isotypes. It promptedindependent experiments with IFN--induced T cell
blasts from a single donor. The generation of IFN-- us to analyze whether this differential transcriptional
responsiveness of K18 would be reflected in a differen-induced blasts was inhibited in a dose-dependent fash-
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Figure 7. The Function of IFN-1/2-Induced SAgs Is Inhibited by Anti-HERV-K18 Antibodies and Correlates with the Strength of Transcriptional
K18 Activation
(A) Polyclonal anti-K18 peptide Abs bind the SAg protein in solution. Rabbit antisera were raised against N- and C-terminal K18.1 peptides.
A C-terminal 3xHA SAg fusion protein was produced in reticulocyte lysates (SAg-3HA RL). Anti-N (-N S) and -C antisera (-C S), but not the
respective preimmune serum (pi S), were capable of immuno-precipitating the SAg fusion as efficiently as anti-HA antibodies (-HA).
(B) Normal rabbit serum, the peak fractions from the first batch of affinity-purified IgGs raised against N- and C-terminal K18.1 peptides
(-N P-IgG1; -C P-IgG1), and the anti-HLA-DR monoclonal antibody L243, were added to PBL cultures from five healthy individuals, which
had been induced by IFN-1/2. The assay was performed as in Figure 4; the percentage of T cell blasts obtained in the presence of normal
rabbit serum is shown as a reference.
(C) Stimulation of SAg-reactive V7 T cells by K18.3 transfectants is inhibited by the second batch of crude anti-N antiserum (-N S2). V7
T cells were stimulated by mouse A20 cells transfected with the full-length envelope allele K18.3 or with the vector control. After 48 hr of
culture, 3H-Thymidine incorporation was measured. Cells were cultured in the presence of anti-N (-N S2) or the respective preimmune serum
(pi S2).
(D) Depletion of anti-N Abs removes the inhibition of SAg function. The peak fraction from the second batch of affinity-purified IgGs (-N
P-IgG2) and the flow-through fraction (-N FT2) depleted of -N-reactive Abs were compared with the crude antiserum (-N S2) and preimmune
serum (pi S2) for their ability to inhibit IFN-1/2-induced T cell blast formation. The average of two independent experiments with IFN--induced
T cell blasts from a single donor is shown. The crude -N antiserum was less consistently inhibiting blast formation than the function of the
transfected K18 SAgs (C).
(E) Depletion of anti-N Abs removes the inhibition of SAg function. The peak fraction from the second batch of affinity-purified IgGs (-N
P-IgG2) and the corresponding flow-through fraction (-N FT2) were compared for their ability to inhibit IFN-1/2-induced T cell blast formation
of four donors.
(F) K18 is induced differentially by type IFNs and this correlates with the strength of the SAg response. IFN-1/2 induces K18 transcription 3
times stronger than IFN-2a and IFN-. PBL from four donors were treated with IFN-1/2, IFN-2a and IFN- for 1 hr and then cultured with
syngeneic PBL. The percentage of blasts in the T cell population was determined as before.
tial blastogenesis, and that is precisely what was consequences. First, endogenous HERV-K18 SAgs in-
duced by viral infections via IFN- provide a model link-found—the IFN-1/2 that most efficiently induced K18
transcriptionally also generated most potently T cell ing environmental factors and disease. Diverse viruses
may trigger autoreactive T cells via induction of endoge-blasts (Figure 7F). Given that different IFN isotypes and
preparations induce other type I IFN target genes with nous SAgs, but autoimmunity will develop only in indi-
viduals that carry some or all genes conferring sus-similar efficiency (Der et al., 1998), this is an additional
argument to suggest that the generation of blasts is the ceptibility to disease. Second, SAg-induced immune
stimulation was proposed to amplify mouse mammaryresult of K18 induction. Therefore, these experiments
strongly suggest that the IFN--induced endogenous tumor virus infection and to favor viral transmission
(Held et al., 1993). By analogy, endogenous HERV-K18HERV-K18 locus encodes MHC class II-dependent SAgs
in all K18 genotypes, comparable to the SAgs encoded SAgs may amplify immune responses during acute and
chronic infections by exogenous viruses. This may favorby the transfected HERV-K18 envelope genes.
These observations could have at least two important the establishment of viral persistence and latency in the
SAg Links Environment and Autoimmunity via IFN-
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course of acute infections and may be a cofactor during of the clinical disease will be required to dissect the
precise role of the SAg in causing pathology.reactivation of persistent infections (Sutkowski et al.,
2001).
Experimental ProceduresWhile IFN--induced endogenous K18 SAgs consti-
tute a novel mechanism that could cause autoimmunity,
Genetic Characterization of HERV-K18many previously known IFN- target genes may act in-
To position the K18 envelope gene and 5 LTR with respect to
dependently of, or jointly with, the SAg. Indeed, type I the first and second CD48 exon, PCR was performed with primers
IFNs exert pleiotropic actions on the innate and adaptive CD48E1F and K18BIF and CD48I1F and CD48E2R, respectively. The
env-LTR fragments of K18 proviruses from 60 different individualsimmune system; for example, they activate and mature
were amplified by PCR with primers K18UTR and K18FLR. PCRmacrophages and dendritic cells, induce isotype switch-
products were directly sequenced and subcloned and the presenceing of B cells, and keep activated T cells alive (Le Page
of all polymorphic sites was confirmed on single molecular cloneset al., 2000). It is also clear that the previously reported
by sequencing (GenBank accession number AF012336).
preliminary association of extracellular IDDMK1,222 tran- K18 typing by PCR and restriction analysis. A 1096 bp fragment
scripts with disease requires revision. First, none of the containing the 3 K18 LTR was amplified with primers K18LTR3 and
K18FLR. The product was digested with BstNI and NsiI and analyzedK18 alleles has functional gag or pol genes that could
on 8% PAGE, which allowed discriminating of all K18 genotypes.be responsible for RT activity or particle production and
Oligonucleotides. 1. Mapping of K18 provirus in CD48 gene.accordingly for the specific extracellular accumulation
CD48E1F 5-CACAGATCTAGAACTAGTGCCACCATGTGCTCCAof K18 transcripts. Therefore, the presence of extracellu-
GAGGTTGG-3;
lar K18 transcripts does not reflect biological activity of K18BIF 5-CTGTCATTTGGATGGGAGACAGGC-3;
the K18 provirus and SAg function. Second, the newly CD48I1F 5-CACGGATCCCAGATTCCGCTTATGTTGTACATGC-3;
CD48E2R 5-CACGTCGACGGAGACCACGGTCATATGTACCAAGTdescribed K18 polymorphism demonstrates that the ge-
GAC-3.netic diversity between alleles of the same K18 provirus
2. Amplification of K18 env gene.can be as great as the variability between individual
K18UTR 5-ATCAGAGATGCAAAGAAAAGC-3;HERV-K proviruses on different chromosomes. This un-
K18FLR 5-ATTGCGGCCGCTCAGTCGACCCCAAACCTTTAAAT
predicted feature redefines the molecular K18 species ATTGTCTCATG-3;
and, as a consequence, also its detection. In summary, K18Kzk 5-ATCAGATCTAACACTAGTGCCACCATGGTAACACCA
GTCA-3;these observations invalidate the earlier described pre-
K18/1689 5-ATTGCGGCCGCTCATGCGACTTACTTATTCATTCAliminary association of extracellular IDDMK1,222 tran-
TGGCCC-3.scripts with disease. However, we provide independent
3. Sequencing of K18 env gene.and novel evidence that indicate how K18 SAgs may be
Amino acid position (aa) 97, 5-ATCAGATCTAACACTAGTGCCA
associated with the onset of type I diabetes, namely via CCATGGTAACACCAGTCACATGG-3; aa 154 and 272, 5-AGAATG
IFN--regulated expression. Increased levels of circulat- TGTGGCCAATAGTGT-3; aa 272, 5-ATGGATGGCGAGGCCTCC
CAC-3; aa 348, 5-AGAGAAGGCATGTGGATCCCT-3.ing IFN- and viral infections have been tightly linked
4. Amplification of K108 env gene.with the onset of type I diabetes. In essence, IFN--
K108UTR 5-ATCAGATCTAACACTAGTCGCTTCACCAGGAGAAAinduced SAgs may link environmental factors and partic-
ATCAGC-3; K108FLR 5-ATTGCGGCCGCTCAGTCGACATTGTCGularly viral infections with the onset of autoimmunity.
GGAGTTCAAGACCAGC-3; K108Kzk 5-ATCAGATCTAACACTAGT
A specific accumulation of V7 T cells had been de- GCCACCATGGACCCATCAGAGATGC-3; K108/1689 5-ATTGCG
scribed in the pancreas and to a lesser extent in the GCCGCTCAGTCGACTTACTTATTCATCTACACAGACACAGTAACA
ATC-3.spleen of patients dying at the onset of type I diabetes
5. Amplification of K104 env gene.from a rare metabolic complication (Conrad et al., 1994).
K104UTR 5-ATCAGATCTAACACTAGTCGCTTCACCAGGAGAAAGiven the rarity of the event, only a few studies exist.
ATCAGC-3; K104FLR 5-ATTGCGGCCGCTCAGTCGACATTGTCTThe technically most comparable study analyzed the
ATTGAGATAATCATGAGG-3; K104Kzk 5-ATCAGATCTAACACTA
infiltrating T cell repertoire molecularly (Somoza et al., GTGCCACCATGGACCCATCGGAGATGC-3; K104Stp 5-ATTGCG
1994) and resulted in findings consistent with ours, GCCGCTCAGTCGACTTACTTATTCATCTATACAGACACAGTAACA
ATC-3.namely that V7 is the single most dominantly used TCR
6. Amplification of CD48 gene.in the pancreas at disease onset. In the second study
5-CACAGATCTAGAACTAGTGCCACCATGTGCTCCAGAGGT(Hanninen et al., 1992), only four V families excluding
TGG-3; 5-CACGCGGCCGCAGAGTCGACTCAATCAATCAGGTAAV7 were analyzed by immuno-fluorescence and there-
GTAACAGG-3.
fore direct comparisons cannot be made. However, a 7. Amplification of probe for K18 read-through transcripts.
recent study analyzed the TCR usage in the circulation 5-AATAGATCTAACACTAGTACATAAGGGAACTCAGAGGCT
GGC-3; 5-AATGCGGCCGCTCAGTCGACATATCCAGTAATGGCAof patients before, at, and after disease onset and com-
ATGCTGGCTATG-3.pared it with that of age-, sex-, and HLA-matched con-
8. Amplification of probe for 6-16 transcripts.trols (Luppi et al., 2000). In this study, circulating levels
5-CggAgATCTCACACTAgTCCAgATgggTTCTCACTATATTg-3;
of V7 and to a lesser extent of V13 T cells were higher 5-TTAgCggCCgCTCAgTCgACATATTgggAATgggggTgTgTgg-3.
before and at disease onset, and higher in diabetics 9. Amplification of 3 K18 LTR for typing.
than in healthy controls. These results are consistent K18LTR3 5-GACAGATCTCACACTAGTGCTACAGTGACATCGAG
AACG-3;with a model in which viral infections induce K18 SAg
K18FLR 5-ATTGCGGCCGCTCAGTCGACCCCAAACCTTTAAATAexpression in circulating APCs, which causes activation
TTGTCTCATG-3.and proliferation of circulating V7 and V13 T cells in
type I diabetes. Finally, persistence of viral infections in
Analysis of SAg Expression
pancreatic  cells and/or a chronic local IFN- response Total RNA was extracted from 2–10 
 107 PBL and 3–10 
 106 cell
could be cofactors in causing Sag-dependent disease. lines. For hybridizations, 15–50 g total RNA was used. Quantifica-
tion was performed with PhosphorImager (Molecular Dynamics).Inhibition of SAg function in vivo during different stages
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Ribonuclease protection assays and the probes protecting a 161 bp Immuno-precipitations using polyclonal rabbit antisera. A C-ter-
minal 3xHA fusion of the SAg (F.M., unpublished data) was pro-human TBP fragment and a 224 bp HLA-A fragment were described
(Reith et al., 1994; Bontron et al., 1997). The other riboprobes were duced in rabbit reticulocyte lysates (Promega). The in vitro produced
protein was incubated with the indicated dilutions of preimmuneas follows. The K18 SAg probe spanned the coding region from nt
162–462. Transcripts were generated with T3 RNA polymerase, after serum, anti-N-, -C-antisera, and with the monoclonal anti-HA anti-
body (HA.11, BabCO) overnight at 4C, followed by incubation for 1.5linearization with AvrII. The undigested probe was 351, the protected
K18 fragment 299, and the protected K108 and K104 fragments hr at room temperature with 20l ProteinA-sepharose in a volume of
100 l. The pellet was washed 3
 in a 0.6% NP40 buffer, and 1/2were 220 nt. The K18 read-through probe was generated by PCR
on genomic DNA. Transcripts were generated with T3, after linear- was resuspended in loading buffer and analyzed by SDS-PAGE.
ization with SpeI. The undigested probe was 365 nt and the pro-
tected fragment 325 nt. The CD48 probe was generated by PCR on Acknowledgments
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